Tokyo Tape
Sign in
← Kaken Pharmaceutical

Quarterly report · Q3

4521.TEDINET S100SS78
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥54.7bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥73.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥55.6bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥8.9bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥12.4bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥9.3bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥8.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥13.0bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥9.2bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥12.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥6.7bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.1bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥6.7bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥9.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥168.3bnat 2023-12-31Cons.Assets
Total assets¥166.3bnat 2023-03-31Cons.Assets
Total assets¥167.8bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥28.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥29.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥140.1bnat 2023-12-31Cons.Net assets
Net assets / equity¥136.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥140.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥51.5bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥59.6bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥177.12023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.852023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.82022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥243.312022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥84.992022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio83.2%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.5%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-12-31¥52.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-12-31¥52.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-12-31¥7.9bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-12-31¥1.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥54.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥54.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥8.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-12-31¥53.8bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-12-31¥53.8bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-12-31¥11.4bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-12-31¥960m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥55.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥55.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥12.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 380
ItemContextValueUnit
Income taxesPrior1YTDDuration3492000000JPY
Income taxesCurrentYTDDuration2545000000JPY
Profit lossPrior1YTDDuration9149000000JPY
Profit lossCurrentYTDDuration6675000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration－JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration－JPY
Profit loss attributable to owners of parentPrior1YTDDuration9149000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration6675000000JPY
Profit lossPrior1YTDDuration9149000000JPY
Profit lossCurrentYTDDuration6675000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration146000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration1392000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration47000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-3000000JPY
Other comprehensive incomePrior1YTDDuration193000000JPY
Other comprehensive incomeCurrentYTDDuration1389000000JPY
Comprehensive incomePrior1YTDDuration9343000000JPY
Comprehensive incomeCurrentYTDDuration8065000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration9343000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration8065000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration－JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration－JPY
Net sales of finished goods and merchandisePrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember52420000000JPY
Net sales of finished goods and merchandisePrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember－JPY
Net sales of finished goods and merchandisePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember52420000000JPY
Net sales of finished goods and merchandisePrior1YTDDuration_ReconcilingItemsMember－JPY
Net sales of finished goods and merchandisePrior1YTDDuration52420000000JPY
RoyaltyPrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember1332000000JPY
RoyaltyPrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember－JPY
RoyaltyPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1332000000JPY
RoyaltyPrior1YTDDuration_ReconcilingItemsMember－JPY
RoyaltyPrior1YTDDuration1332000000JPY
Other incomePrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember－JPY
Other incomePrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember1820000000JPY
Other incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1820000000JPY
Other incomePrior1YTDDuration_ReconcilingItemsMember－JPY
Other incomePrior1YTDDuration1820000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember53753000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember1820000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember55573000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration55573000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E00935-000MedicineReportableSegmentsMember53753000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E00935-000RealEstateReportableSegmentsMember1820000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember55573000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass